Changeflow GovPing Healthcare Welch Allyn Spot Vision Screener VS100 Software...
Urgent Enforcement Amended Final

Welch Allyn Spot Vision Screener VS100 Software Issue May Cause Screen Flicker Triggering Seizures

Favicon for changeflow.com FDA: Device Recalls Class II
Filed
Detected
Email

Summary

FDA issued a Class II recall for Welch Allyn Spot Vision Screener VS100 devices due to a software defect causing display screen flicker. The flickering may induce photosensitive seizure activity in susceptible individuals. Affected devices run software version 3.2.0.1 and are distributed nationwide across 15 US states plus Colombia and India. The recall is classified as ongoing.

What changed

FDA issued a Class II medical device recall for Welch Allyn Spot Vision Screener VS100 models running software version 3.2.0.1. The recall addresses a software defect causing the display screen to flicker unintentionally, which may trigger photosensitive seizure activity in susceptible individuals. The affected devices were distributed to 15 US states and internationally to Colombia and India.\n\nHealthcare providers and facilities using these vision screening devices should immediately assess their inventory for affected units, discontinue clinical use pending software correction or device replacement, and monitor FDA communications for updated remediation instructions. This recall affects medical device manufacturers and healthcare providers performing vision screening examinations, particularly pediatric and population health screening programs where these devices are commonly deployed.

What to do next

  1. Discontinue use of affected Welch Allyn VS100 devices
  2. Contact Baxter Healthcare for replacement or software fix
  3. Report adverse events to FDA MedWatch

Archived snapshot

Apr 11, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Baxter Healthcare Corporation

Device Recalls (Class II)

← All Device Recalls (Class II) Class II Z-1573-2026 · 20260325 · Ongoing

Product

Brand Name: Welch Allyn, Inc. Product Name: Welch Allyn Spot Vision Screener VS100 Model/Catalog Number: VS100 Software Version: Software version 3.2.0.1 Product Description: Welch Allyn Spot V...

Reason for Recall

Display screen may unintentionally flicker due to a software issue. Exposure to flickering lights may induce photosensitive seizure activity in susceptible individuals.

Distribution

Worldwide - US Nationwide distribution in the states of AZ, CO, IL, IN, KS, MA, NE, NJ, NM, NY, PA, SC, TX, VA and the countries of Colombia and In...

Source: openFDA Enforcement API

Get daily alerts for FDA: Device Recalls Class II

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Filed
March 25th, 2026
Instrument
Enforcement
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
Z-1573-2026
Docket
Z-1573-2026

Who this affects

Applies to
Medical device makers Healthcare providers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Vision screening devices Medical device software Seizure risk assessment
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Product Safety Healthcare

Get alerts for this source

We'll email you when FDA: Device Recalls Class II publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!